AROVELLA THERAPEUTIC ORDINARY (ALA) Short Interest
AROVELLA THERAPEUTIC ORDINARY (ASX:ALA) had 0.00% of shares reported as short positions as of 26 June 2026, representing 1,800 shares. AROVELLA THERAPEUTIC ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
ALA
Arovella Therapeutics
Arovella Therapeutics Limited is a biotechnology company developing a platform of invariant Natural Killer T (iNKT) cells for treating cancer. The company aims to harness this platform to create innovative and targeted cancer therapies, positioning itself at the forefront of biotechnology advances. Arovella's unique approach targets unmet medical needs, offering potential breakthroughs in cancer t...